DAS28, 28 joint count Disease Activity Score

Glucocorticoid resorption and influence on the hypothalamic-pituitary-adrenal axis after intra-articular treatment of the knee in resting and mobile patients
T Weitoft, L Rönnblom

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 955-957; DOI: 10.1136/ard.2005.041525
Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis
A Finckh, J F Simard, C Gabay, P-A Guerne

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 746-752; DOI: 10.1136/ard.2005.045062
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
M E Weinblatt, E C Keystone, D E Furst, A F Kavanaugh, E K Chartash, O G Segurado

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 753-759; DOI: 10.1136/ard.2005.044404
Swedish registers to examine drug safety and clinical issues in RA
J Askling, C M Fored, P Geborek, L T H Jacobsson, R van Vollenhoven, N Feltelius, S Lindblad, L Klareskog

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 707-712; DOI: 10.1136/ard.2005.045872
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis
V P K Nell, K P Machold, T A Stamm, G Eberl, H Heinzl, M Uffmann, J S Smolen, G Steiner

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1731-1736; DOI: 10.1136/ard.2005.035691
Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression
J Rönnelid, M C Wick, J Lampa, S Lindblad, B Nordmark, L Klareskog, R F van Vollenhoven

Annals of the Rheumatic Diseases Dec 2005, 64 (12) 1744-1749; DOI: 10.1136/ard.2004.033571
Blockade of tumour necrosis factor α significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis
B Yazdani-Biuki, E Stadlmaier, A Mulabecirovic, R Brezinschek, G Tilz, U Demel, T Mueller, K Brickmann, W B Graninger, H-P Brezinschek

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1224-1226; DOI: 10.1136/ard.2004.030262
Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial
G Kobelt, P Lindgren, A Singh, L Klareskog

Annals of the Rheumatic Diseases Aug 2005, 64 (8) 1174-1179; DOI: 10.1136/ard.2004.032789
Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis
H Schotte, B Schlüter, S Drynda, P Willeke, N Tidow, G Assmann, W Domschke, J Kekow, M Gaubitz

Annals of the Rheumatic Diseases Apr 2005, 64 (4) 575-581; DOI: 10.1136/ard.2004.027672
Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)
A Kastbom, G Strandberg, A Lindroos, T Skogh

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1085-1089; DOI: 10.1136/ard.2003.016808

Log in using your username and password

Main menu

Log in using your username and password

You are here

DAS28, 28 joint count Disease Activity Score